DeepIntent
DeepIntent is a healthcare-specialized demand-side platform that enables pharmaceutical brands and agencies to plan, activate, and optimize programmatic advertising across CTV, display, audio, video, and EHR channels, reaching 98% of US prescribing HCPs and 250M+ patient profiles.
- Company typePrivate
- Founded2016
- HeadquartersNew York, United States
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What DeepIntent does
DeepIntent is a healthcare-specialized demand-side platform (DSP) founded in 2016 and headquartered in New York City, with an engineering office in Pune, India. The company unifies media, identity, and clinical data through its proprietary Health Intelligence technology to enable pharmaceutical brands and their agencies to plan, activate, and optimize programmatic advertising campaigns across omnichannel touchpoints including CTV, display, native, audio, DOOH, video, and EHR environments. Its data footprint spans 3.7 million+ verified healthcare professionals (covering 98% of the US prescribing HCP universe) and 250 million+ patient profiles, refreshed daily via claims data. The platform powers 600+ pharmaceutical brands and is used by all leading healthcare agencies, including Merck, AstraZeneca, Pfizer, Gilead, Teva, and Amgen on the brand side and Publicis Health Media, Deerfield Group, and Good Apple on the agency side.
The product architecture combines the core DeepIntent DSP with the Cortex optimization layer and the newly launched Helix healthcare marketing cloud (March 2026) and Helix AI agentic AI layer (June 2026). Helix AI enables natural language querying of healthcare data, audience building, and cross-platform campaign activation, reportedly cutting planning cycle time by 50% in beta testing. The company holds three patents, maintains HIPAA and NAI compliance, and operates certification programs (DSP, Cortex Essentials, Digital Health Marketing/Targeting) to deepen client embedment. Recent strategic integrations with OptimizeRx, epocrates, and Lane4.io extend programmatic reach into authenticated EHR and point-of-care inventory, areas previously inaccessible to generalist DSPs.
DeepIntent monetizes primarily through DSP fees on programmatic media buying, supplemented by data and audience services (premium health data segments and measurement) and managed services. Pricing is enterprise-oriented, quote-based, and structured around multi-year contracts, with both self-service platform access and full-service managed campaign execution available. In September 2025, the company secured a $637 million private equity investment from Vitruvian Partners, the largest funding in its history, intended to accelerate its AI-driven transformation of healthcare marketing.
DeepIntent firmographics
Firmographics- Name
- DeepIntent
- Legal name
- DeepIntent, Inc.
- Website
- https://deepintent.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- DeepIntent is a healthcare-specialized demand-side platform that enables pharmaceutical brands and agencies to plan, activate, and optimize programmatic advertising across CTV, display, audio, video, and EHR channels, reaching 98% of US prescribing HCPs and 250M+ patient profiles.
- Ownership category
- akta.pro rank
DeepIntent industry classification
Industry- Product category
- Healthcare Advertising Demand-Side Platform (DSP)
- NAICS
- Media Buying Agencies (541830), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Healthcare/Pharma Creative Agencies (MPAAAAAJ)
Keywords
Where DeepIntent is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
DeepIntent business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- Demand-Side Platform (DSP) Fees: DeepIntent operates as a healthcare-specific demand-side platform, charging fees for programmatic media buying and advertising technology services to pharmaceutical brands and agencies.
- Data and Audience Services: Revenue generated from providing premium health data segments, advanced targeting capabilities, and measurement products to healthcare marketers.
- Managed Services: Expert campaign assistance including planning, activation, and optimization services for clients requiring hands-on support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise healthcare advertising platform with managed service and self-service options |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
DeepIntent product offering
Product offeringCore offering
DeepIntent operates a healthcare-specific demand-side platform (DSP) that enables pharmaceutical brands and agencies to plan, activate, and optimize programmatic advertising campaigns across audio, CTV, display/native, DOOH, EHR, and video channels. The platform unifies media, identity, and clinical data through its proprietary Health Intelligence™ technology, allowing precision targeting of 3.7M+ verified healthcare professionals and 250M+ patient profiles in a HIPAA- and NAI-compliant environment. It sells directly to enterprise pharma companies and healthcare agencies, supplemented by managed services and data/audience offerings.
Product overview
DeepIntent is a healthcare advertising demand-side platform (DSP) offering a unified platform-plus-modules architecture. The core DeepIntent platform enables programmatic media buying across healthcare channels (CTV, display, video, audio, DOOH, EHR) powered by patented health intelligence technology. Key modules include: Helix™ (healthcare marketing cloud launched March 2026) and Helix AI (agentic AI layer launched June 2026 enabling natural language querying of 4M+ HCPs and 250M+ patient profiles); DeepIntent Cortex™ (intelligence layer for optimization and audience quality); and HealthFirst™ Media Suite (premium inventory packages). The platform is HIPAA and NAI-compliant and reaches 98% of the prescribing HCP universe with 3.7M+ verified HCPs and 250M+ patient profiles.
Differentiator
Problem solved
Functional benefit
Brands
- Helix: Purpose-built healthcare marketing cloud platform that enables marketers to explore healthcare data, build audiences, and activate campaigns using natural language.
- Helix AI
- Cortex
- HealthFirst
Products and services
- DeepIntent Platform Healthcare advertising demand-side platform (DSP) that unites media, identity, and clinical data to enable programmatic ad buying across healthcare channels including CTV, display, video, audio, DOOH, and EHR. Powers campaigns for pharmaceutical brands with real-time optimization and reaches 98% of prescribing HCPs.
- Helix™ Healthcare Marketing Cloud Purpose-built healthcare marketing cloud providing integrated audience building, campaign activation, and commercial insights capabilities for healthcare marketers on top of DeepIntent's DSP.
- Helix AI Agentic AI platform purpose-built for healthcare marketers enabling natural language querying of healthcare databases covering 4M+ HCPs and 250M+ patient lives, audience building, and cross-platform campaign activation. Reduces planning cycle time by 50%.
- DeepIntent Cortex™ AI-powered health intelligence optimization and decisioning technology combining clinical and media data for smarter media buying, real-time optimization, and scalable campaign performance across healthcare KPIs.
- HCP Solutions Healthcare professional engagement solution enabling precision targeting and scale to verified HCPs (3.7M+) for meaningful pharma campaign impact across omnichannel programmatic inventory.
- DTC Solutions Direct-to-consumer campaign solutions using data-driven targeting to connect pharmaceutical brands with 250M+ patient profiles at the right moment for effective patient campaigns.
- Integrated Solutions Unified approach bridging HCP and DTC engagement to maximize reach and amplify outcomes across the patient care journey with cross-channel optimization.
- Custom Solutions (Managed Services) Managed services providing expert campaign assistance including planning, activation, and optimization support delivered by DeepIntent specialists for clients requiring hands-on support.
- HealthFirst™ Media Suite Media package solution offering premium inventory and audio packages for connecting healthcare brands to trusted streaming publishers, including HealthFirst Vaccine Audiences recognized as an innovation by PM360 in 2024.
- FAST Solution Free Ad-Supported TV solution connecting healthcare brands to premium streaming supply at scale.
Quantifiable outcome
- 50% improvement in planning cycle time for agency users
- +3 more outcomes
Companies that use DeepIntent
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles2 records
DeepIntent technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability4 records
Feature7 records
DeepIntent partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- Lane4.iocorePartnership to launch a new programmatic path to point-of-care inventory. Lane4.io is a supply-side platform built specifically for Electronic Health Record (EHR) and health media advertising. The partnership aims to expand programmatic access to point-of-care media with new features launching mid-June 2026.
- epocratescoreFirst-to-market partnership making epocrates' clinical inventory programmatically available within the epocrates clinician workflow. The integration enables advertisers to reach verified healthcare professionals at the point of care using real-time contextual signals, including drug lookups and clinical activity, within a logged-in, brand-safe environment.
- OptimizeRxcoreDeepIntent became the first DSP to integrate OptimizeRx's proprietary authenticated electronic health record (EHR) network into its advertising platform. The integration enables life sciences marketers to activate advertising within healthcare provider workflows at clinically relevant decision moments using a privacy-safe solution. Expected to be available in Q3 2026.
- MAGNA (IPG Mediabrands)coreResearch partnership conducting the 'Beyond the Prescription' study exploring the impact of pharmaceutical advertising on patient behavior, health management, and outcomes. The proprietary research surveyed over 1,100 patients and 1,000 doctors to uncover how pharma ads influence patient health outcomes beyond traditional promotional roles.
- Everyday Health GroupcoreStrategic partnership providing agencies and brands priority access to Everyday Health Group's premium health-focused platform with trusted and reviewed health content. Includes first-look access to EHG's premium inventory across properties including Everyday Health, BabyCenter, WhatToExpect, MedPage Today, and EHG's Trusted Care Access Portfolio (TCAP) of leading medical center sites.
- Publicis Health MediacoreAgency partnership where Publicis Health Media utilizes DeepIntent's platform for healthcare advertising campaigns. Publicis CEO Andrea Palmer noted that the partnership has simplified go-to-market strategy for clients' campaigns by enhancing speed and access to unique data and inventory.
- Deerfield GroupcoreStrategic partnership combining DeepIntent's platform with Deerfield Group's healthcare marketing and media expertise to deliver meaningful impact. The partnership leverages high-quality data, premium inventory access, and commitment to innovation to craft strategies that accelerate brand growth.
Scale indicators7 records
Recent moves6 records
Expansion highlights7 records
DeepIntent competitors and assessment
Company assessmentDirect peers
- Pulsepoint: Pulsepoint operates a programmatic ad-tech platform with significant healthcare vertical focus, competing directly with DeepIntent for pharma brand and agency budgets in omnichannel programmatic buying. Both companies serve the HCP and DTC healthcare advertising market with comparable DSP capabilities.
- Swoop (IQVIA): Swoop, now part of IQVIA, provides healthcare-specific audience targeting, identity resolution, and programmatic activation—directly competing with DeepIntent's Health Intelligence capabilities. Both companies leverage health data assets to enable pharma marketers to reach HCPs and patients with privacy-safe precision.
- Crossix (Veeva Systems): Crossix, now part of Veeva, offers healthcare marketing analytics and audience solutions for pharma brands, competing with DeepIntent's measurement and targeting capabilities. Both serve pharma marketers with clinical data integration and campaign analytics for measuring script lift and audience quality.
Emerging players
- PatientPoint: PatientPoint is a point-of-care health media company reaching patients and HCPs in physician offices, partially overlapping with DeepIntent's recent EHR/point-of-care expansion. Their owned inventory represents a complementary or competitive channel for pharma advertisers depending on integration terms.
- Outcome Health: Outcome Health provides point-of-care health media and HCP engagement solutions across digital channels in clinical settings. Their EHR-integrated advertising platform overlaps with DeepIntent's emerging point-of-care inventory partnerships, particularly for reaching verified HCPs at clinical decision moments.
Broad incumbents
- The Trade Desk: The Trade Desk is the largest independent DSP globally, with growing healthcare vertical investment that directly competes with DeepIntent for pharma programmatic budgets. While not healthcare-specific, its scale, data partnerships, and recent recruitment of DeepIntent's prior CMO position it as a major competitive threat.
- WebMD (Internet Brands): WebMD operates one of the largest health information and DTC advertising platforms, serving both endemic pharma advertising and broader health audiences. Its massive consumer health audience represents both a potential inventory partner and a competing advertising destination for pharma brands.
Others
- LiveRamp: LiveRamp provides identity resolution and data collaboration infrastructure that underpins much of the programmatic ecosystem, including healthcare advertising. While not a direct competitor, DeepIntent depends on similar data infrastructure for its targeting capabilities, making LiveRamp both an enabler and potential disintermediator.
- Definitive Healthcare: Definitive Healthcare provides healthcare commercial intelligence and data analytics used by pharma marketers for HCP targeting and market intelligence. While primarily a data/analytics provider rather than an ad-tech platform, its healthcare data assets overlap with DeepIntent's HCP targeting capabilities.
- Magnite: Magnite is the largest independent sell-side platform (SSP) for CTV and video advertising, supplying inventory that DeepIntent's DSP activates for pharma marketers. As a critical infrastructure provider in the programmatic ecosystem, Magnite's pricing and policies directly impact DeepIntent's unit economics on CTV campaigns.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
DeepIntent social profiles
Digital presenceDeepIntent compliance and trust
Trust signalCompliance2 records
DeepIntent financial estimates
Financial estimateRevenue estimate
Valuation estimate
DeepIntent leadership team
Management profileNumber of profiles
Profiles18 records
DeepIntent funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DeepIntent M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DeepIntent
What does DeepIntent do?
DeepIntent operates a healthcare-specific demand-side platform (DSP) that enables pharmaceutical brands and agencies to plan, activate, and optimize programmatic advertising campaigns across audio, CTV, display/native, DOOH, EHR, and video channels. The platform unifies media, identity, and clinical data through its proprietary Health Intelligence™ technology, allowing precision targeting of 3.7M+ verified healthcare professionals and 250M+ patient profiles in a HIPAA- and NAI-compliant environment. It sells directly to enterprise pharma companies and healthcare agencies, supplemented by managed services and data/audience offerings.
Is DeepIntent a public or private company?
DeepIntent is a private company. It is classified as private equity controlled and is currently operating.
When was DeepIntent founded?
DeepIntent was founded in 2016. It employs 251 to 500 people.
Where is DeepIntent based?
DeepIntent is headquartered in New York, United States, in the North America region.
How does DeepIntent make money?
Three revenue lines are on record. Demand-Side Platform (DSP) Fees are the primary driver. The others are data and Audience Services and managed Services.
Who are DeepIntent's main competitors?
Direct peers on record are Pulsepoint, Swoop (IQVIA) and Crossix (Veeva Systems). Emerging players are PatientPoint and Outcome Health. Broad incumbents are The Trade Desk and WebMD (Internet Brands). Others are LiveRamp, Definitive Healthcare and Magnite.
Does DeepIntent have an API?
No public API is recorded for DeepIntent.
What industry is DeepIntent in?
DeepIntent's product category is Healthcare Advertising Demand-Side Platform (DSP). Its primary akta.pro industry code is MPAAAAAJ, Healthcare/Pharma Creative Agencies. Its NAICS code is 541830 and its SIC code is 8000.